Pinnacle Associates LTD Gilead Sciences, Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 59,814 shares of GILD stock, worth $5.38 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

59,814

Previous 99,145 39.67%

Holding current value

$5.38 Million

Previous $6.8 Million 26.3%

% of portfolio

0.08%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$66.59 - $83.99 $2.62 Million - $3.3 Million	-39,331 Reduced 39.67%	59,814 $5.01 Million
Q2 2024 Jul 30, 2024	BUY	$63.15 - $72.88 $2.53 Million - $2.92 Million	40,122 Added 67.98%	99,145 $6.8 Million
Q1 2024 Apr 26, 2024	SELL	$71.58 - $87.29 $56,619 - $69,046	-791 Reduced 1.32%	59,023 $4.32 Million
Q4 2023 Jan 19, 2024	BUY	$73.27 - $83.09 $75,687 - $85,831	1,033 Added 1.76%	59,814 $4.85 Million
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $273,651 - $298,559	-3,701 Reduced 5.92%	58,781 $4.41 Million
Q2 2023 Jul 26, 2023	SELL	$76.01 - $86.7 $181,207 - $206,692	-2,384 Reduced 3.68%	62,482 $4.82 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $253,112 - $288,373	-3,274 Reduced 4.8%	64,866 $5.38 Million
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $84,443 - $121,231	-1,355 Reduced 1.95%	68,140 $5.85 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $28,667 - $41,156	-460 Reduced 0.66%	69,495 $0
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $374,030 - $427,238	-6,282 Reduced 8.24%	69,955 $4.32 Million
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $315,728 - $355,604	-5,470 Reduced 6.69%	76,237 $4.71 Million
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $321,398 - $402,746	-5,549 Reduced 6.36%	81,707 $4.86 Million
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $942,446 - $1.07 Million	-14,526 Reduced 14.27%	87,256 $6.34 Million
Q3 2021 Oct 19, 2021	SELL	$67.69 - $73.03 $96,999 - $104,651	-1,433 Reduced 1.39%	101,782 $7.11 Million
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $1.01 Million - $1.1 Million	-15,861 Reduced 13.32%	103,215 $7.11 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $284,040 - $324,089	-4,734 Reduced 3.82%	119,076 $7.7 Million
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $3.29 Million - $3.75 Million	-58,146 Reduced 31.96%	123,810 $7.21 Million
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $536,171 - $674,142	-8,634 Reduced 4.53%	181,956 $11.5 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $837,841 - $972,888	-11,582 Reduced 5.73%	190,590 $14.7 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $162,462 - $208,090	2,594 Added 1.3%	202,172 $15.1 Million
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $1.59 Million - $1.75 Million	-25,780 Reduced 11.44%	199,578 $13 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $117,581 - $129,789	-1,881 Reduced 0.83%	225,358 $14.3 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $171,441 - $192,251	-2,771 Reduced 1.2%	227,239 $15.4 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $300,956 - $337,150	4,813 Added 2.14%	230,010 $15 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $2.39 Million - $3.12 Million	-39,549 Reduced 14.94%	225,197 $14.1 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $903,402 - $1 Million	-12,674 Reduced 4.57%	264,746 $20.4 Million
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $823,002 - $960,000	-12,685 Reduced 4.37%	277,420 $19.7 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $136,065 - $165,878	-1,868 Reduced 0.64%	290,105 $21.9 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $612,530 - $719,023	-8,609 Reduced 2.86%	291,973 $20.9 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $149,051 - $176,666	-2,067 Reduced 0.68%	300,582 $24.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	302,649	302,649 $21.4 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Gilead Sciences, Inc. Transaction History